Genetically proxied therapeutic prolyl-hydroxylase inhibition and cardiovascular risk. (2023)
Attributed to:
Using genetics to test the disease consequences of higher adiposity uncoupled from its adverse metabolic effects
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddac215
PubMed Identifier: 36048866
Publication URI: http://europepmc.org/abstract/MED/36048866
Type: Journal Article/Review
Volume: 32
Parent Publication: Human molecular genetics
Issue: 3
ISSN: 0964-6906